Insider Transactions Reported by 20 Insiders of VERACYTE, INC.

Symbol
VCYT on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

VERACYTE, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marc Stapley Chief Executive Officer, Director $15.1M -$2.35M -13.5% 02 Dec 2025
Rebecca Chambers Chief Financial Officer $5.17M -$932K -15.3% 02 Dec 2025
Tina Susan Nova President, CLIA U.S. $4.78M 03 Mar 2022
Bonnie Anderson Director $4.68M 02 Jun 2023
Phillip G. Febbo Chief Scientific & Med Officer $4.13M -$569K -12.1% 02 Dec 2025
John Leite Chief Commercial Officer-CLIA $3.9M -$795K -16.9% 02 Dec 2025
Annie McGuire SVP, General Counsel $2.96M -$980K -24.9% 16 Dec 2025
ROBERT S. EPSTEIN Director $2.19M -$753K -25.6% 01 Oct 2025
Giulia C. Kennedy Chief Scientific & Med Officer $1.75M 06 Dec 2022
Jonathan Wygant VP, Chief Accounting Officer $1.73M -$450K -20.7% 02 Dec 2025
EVAN/ FA JONES Director $1.48M -$2M -57.6% 25 Nov 2025
Eliav Barr Director $1.47M 18 Jun 2025
JOHN L. BISHOP Director $1.28M 17 Jul 2023
Jens Holstein Director $1.18M -$424K -26.5% 20 Nov 2025
Muna Bhanji Director $1.13M -$122K -9.75% 18 Jun 2025
David Brent Shafer Director $744K 18 Jun 2025
Thomas F. Miller Director $744K 18 Jun 2025
KARIN EASTHAM Director $631K -$1.82M -74.3% 05 Dec 2025
Jane Alley VP, Corporate Controller $345K 17 May 2021
KEVIN K. GORDON Director $231K 08 Jun 2022

Recent Insider Transactions by Companies or Individuals for VERACYTE, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.